S Bank Fund Management Ltd increased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 9.7% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 13,162 shares of the semiconductor company’s stock after purchasing an additional 1,166 shares during the quarter. S Bank Fund Management Ltd’s holdings in Synopsys were worth $6,494,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Brighton Jones LLC increased its position in shares of Synopsys by 5.7% in the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after acquiring an additional 50 shares in the last quarter. Integrated Wealth Concepts LLC lifted its holdings in shares of Synopsys by 11.6% during the 1st quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company’s stock valued at $326,000 after acquiring an additional 79 shares in the last quarter. NewEdge Advisors LLC boosted its position in Synopsys by 15.1% during the 1st quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company’s stock worth $1,291,000 after purchasing an additional 395 shares during the period. Voya Investment Management LLC increased its holdings in Synopsys by 23.4% in the 1st quarter. Voya Investment Management LLC now owns 59,467 shares of the semiconductor company’s stock valued at $25,502,000 after purchasing an additional 11,260 shares in the last quarter. Finally, Gradient Investments LLC increased its holdings in Synopsys by 28.8% in the 2nd quarter. Gradient Investments LLC now owns 41,237 shares of the semiconductor company’s stock valued at $21,141,000 after purchasing an additional 9,215 shares in the last quarter. 85.47% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
SNPS has been the subject of several analyst reports. Citigroup assumed coverage on Synopsys in a research report on Monday, November 24th. They issued a “buy” rating and a $580.00 target price for the company. Needham & Company LLC upped their price target on Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and reduced their target price for the stock from $525.00 to $500.00 in a research report on Monday, December 8th. Wall Street Zen raised shares of Synopsys from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. Finally, KeyCorp boosted their price objective on shares of Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. Nine research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $553.57.
Insiders Place Their Bets
In other news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Janet Lee sold 250 shares of the stock in a transaction dated Wednesday, January 7th. The stock was sold at an average price of $510.00, for a total transaction of $127,500.00. Following the sale, the insider owned 12,209 shares in the company, valued at approximately $6,226,590. This trade represents a 2.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.62% of the company’s stock.
Synopsys Stock Performance
Shares of Synopsys stock opened at $533.42 on Tuesday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The firm’s 50-day simple moving average is $446.82 and its 200-day simple moving average is $504.96. The firm has a market cap of $102.05 billion, a PE ratio of 66.76, a price-to-earnings-growth ratio of 4.37 and a beta of 1.12.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.11. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same period in the previous year, the company earned $3.40 earnings per share. Synopsys’s quarterly revenue was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Equities analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
- Five stocks we like better than Synopsys
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
